• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.04% Nasdaq Up 0.34%

    Ocera Therapeutics, Inc. (OCRX)

    -NasdaqGM
    4.05 Up 0.21(5.47%) 11:33AM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:3.84
    Open:3.83
    Bid:4.01 x 300
    Ask:4.07 x 100
    1y Target Est:16.00
    Beta:3.83
    Earnings Date:Aug 10 - Aug 14 (Est.)
    Day's Range:3.83 - 4.06
    52wk Range:3.30 - 8.10
    Volume:7,338
    Avg Vol (3m):87,214
    Market Cap:79.98M
    P/E (ttm):N/A
    EPS (ttm):-1.40
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for OCRX

    Comparison

    Symbol% ChgMkt Cap
    OCRXUp 5.47%79.98M
    IRWDUp 1.81%1.51B
    THRXUp 1.96%1.70B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):231.89
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.52
    Quarterly EPS Est (Jun-15) :-0.40
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Ocera Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the development and commercialization of OCR-002, which is in Phase IIb trials for the treatment of hyperammonemia and hepatic encephalopathy in patient... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback